New York, NY, July 17, 2019 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Active Pharmaceutical Ingredients Market by API Synthesis (Biotech API, Synthetic Chemical API, and HPAPI), by Type of Manufacturing (Contract Manufacturing and In-House API Manufacturing), by Type of API (Synthetic API and Biological API), by Drug type (Into Branded Drugs, Generic Drugs and OTC Drugs), for Cardiology, Oncology, Anti-Inflammatory, Gastrointestinal and Other Application - Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021”.
According to the report, the global active pharmaceutical ingredients market stood at US$ 148.22 billion in 2015. Witnessing a tremendous rise during the period from 2015 to 2021, the revenue in the active pharmaceutical ingredients market is expected to reach US$ 213.84 billion by the end of the forecast period.
With the presence of a large pool of participants, the global active pharmaceutical ingredients market is displaying a highly competitive business landscape, finds a new research report by Zion Market Research (ZMR). Novartis International AG, Albemarle Corporation, BASF SE, Boehringer Ingelheim, and Pfizer Inc. are some of the key vendors of active pharmaceutical ingredients across the world. These players across active pharmaceutical ingredients market are focusing aggressively on innovation, as well as on including advanced technologies in their existing products. Over the coming years, they are also expected to take up partnerships and mergers and acquisitions as their key strategy for business development, states the global active pharmaceutical ingredients market study.
Browse through 68 Tables & 48 Figures spread over 110 Pages and in-depth TOC on “Active Pharmaceutical Ingredients (API) Market Size & Trends and Global Forecast 2021”.
Request Sample Report of Global Active Pharmaceutical Ingredients Market @ https://www.zionmarketresearch.com/sample/active-pharmaceutical-ingredients-market
Citing an instance, in August 2018, Fagron Inc. presented a TrichoConcept™, a first universal line of multifunctional vehicles equipped with patented TrichoTech™ technology, which balances overall hair system including bulb, shaft, and scalp. Reportedly, this line of hair care vehicles was created with a view to provide health care service providers with greater alternatives for delivering various active pharmaceutical ingredients as well as dermaceutical ingredients for effective personalized hair care treatment. This is likely to favorably influence active pharmaceutical ingredients market revenue in the coming years.
Active pharmaceutical ingredient (API) is used in the manufacturing of a pharmaceutical drug as a biologically active compound. API is an organic compound which has unique chemical structure and stereochemistry. Any medication is made up of two portions. The first is the active pharmaceutical ingredients, which is the essential element of the drug. The second is known as an excipient which is an inner part of the drug. The active pharmaceutical ingredient is the chemically active substance, which is intended to deliver the desirable impact in the body.
Request for PDF Brochure of This Report: https://www.zionmarketresearch.com/requestbrochure/active-pharmaceutical-ingredients-market
The market for API is driven by a number of factors, such as increasing prevalence of chronic diseases, technological advancements in the API manufacturing, and growing incidences of age-related diseases. Furthermore, patent expiration of major drugs that increased generic drug sales, government initiatives flourishing the market growth. However, stringent regulatory requirement and decline in global economics may curb the worldwide active pharmaceutical ingredient market.
The global active pharmaceutical ingredient market is broadly segmented based on API synthesis, type of manufacturing, type of API, and type of drug, application and by region. On the basis of API, synthesis market is segmented into biotech API, synthetic chemical API, and HPAPI (Highly Potent Active Pharmaceutical Ingredient). The biotech API is the leading segment and acquired a significant share in overall API market in 2015. On the basis of the type of manufacturing, the market is segmented into API contract manufacturing and in-house API manufacturing. The contract manufacturing emerged as major segment due to lower cost and higher quality of production of the API. Type segment of API includes synthetic API and biological API.
This review is based on a report by Zion Market Research, titled "Active Pharmaceutical Ingredients Market by API Synthesis (Biotech API, Synthetic Chemical API, and HPAPI), by Type of Manufacturing (Contract Manufacturing and In-House API Manufacturing), by Type of API (Synthetic API and Biological API), by Drug type (Into Branded Drugs, Generic Drugs and OTC Drugs), for Cardiology, Oncology, Anti-Inflammatory, Gastrointestinal and Other Application - Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021"- Report at http://www.zionmarketresearch.com/report/active-pharmaceutical-ingredients-market
By type of drug, the market is segmented into branded drugs, generic drugs, and OTC (Over the Counter) drugs. The generic prescription drugs segment is expected to witness the highest growth in the upcoming years due to their low cost compared to branded drugs. Cardiology, oncology, anti-inflammatory, gastrointestinal and others are the key therapeutic application segmentation of API market. According to World Health Organization (WHO), cancer was one of the major causes of mortality across the globe. Thus, the oncology segment is expected to be the fastest-growing segment of the global API market.
Product Innovations In Pharma Sector To Support North American Dominance
Regionally, North America has been leading the worldwide active pharmaceutical ingredients market and is anticipated to continue on the dominant position in the years to come, states the market study. New technological breakthroughs along with new product developments are the key factor behind the dominance of the North America active pharmaceutical ingredients market. The huge presence of giant pharmaceutical firms in North America is another significant factor lucratively leveraging the growth of North America active pharmaceutical ingredients market.
Inquire more about this report before purchase @ https://www.zionmarketresearch.com/inquiry/active-pharmaceutical-ingredients-market
The global active pharmaceutical ingredients market is segmented as follows:
By API Synthesis
- Biotech API
- Synthetic Chemical API
- HPAPI
By Manufacturing Segment Type
- Contract Manufacturing
- In-House API Manufacturing
By API Segment Type
- Synthetic API
- Biological API
By Drug Type
- Branded Drugs
- Generic Drugs
- OTC Drugs
By Therapeutic Application
- Cardiology
- Oncology
- Anti-Inflammatory
- Gastrointestinal
- Other
By Region
- North America
- The U.S.
- Europe
- UK
- France
- Germany
- Asia Pacific
- China
- Japan
- India
- Latin America
- Brazil
- The Middle East and Africa
Request customized copy of report @ https://www.zionmarketresearch.com/custom/56
About Us:
Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Follow Us LinkedIn: https://www.linkedin.com/company/zion-market-research
Follow Us Twitter: https://twitter.com/zion_research
Contact Us:
Joel John
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com
Blog: http://zmrblog.com